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Introduction
Kawasaki disease (KD) is an acute self-limited systemic
vasculitis relatively common in childhood. In Japan, last
published survey shows an incidence up to 239.6/105
children <5 years old (yo). In Madrid (Spain) a retrospec-
tive study with no well defined reference area showed an
incidence of 15.1/105 children <5yo.
Objectives
To ascertain the incidence and clinical features of KD in
Catalonia, autonomous region in northeast Spain with
7.5 million inhabitants.
Methods
Observational population-based study including all
Catalan hospitals with Pediatric Units, both public and
private management. Retrospective data retrieval was per-
formed for the last 10 years (2004-2013). The presence of
coronary aneurysms (CA) in echocardiology was based in
the body surface area according to the American Heart
Association.
Results
Data from 399 patients from 33 different hospitals was
analyzed. Of those, 233 (58.4%) patients had complete
KD, 159 (39.8) incomplete KD and 7 (1.7%) were con-
sidered atypical KD. The mean annual incidence was
3.5/105 children <14yo and 8/105 children<5yo (mean
age 37±33months(m), range 1.3-191.3m). KD was more
frequent among boys (59.6%, p<0.01). Mean delay
between onset of the disease and diagnostic was
7.2±5.3 days. Ethnic distribution was: Caucasian
279 patients(69.9%), North African 26 (6.5%), Amerindian
21 (5.2%), Asian 14 (3.5%) and Sub-Saharan 4 (1%).
Ethnicity was not available in 55 (13.8%) patients. Distribu-
tion of classical manifestations for KD was: fever in 100%
of patients, changes in extremities 40.3% (desquamation in
31% of them), exanthema 84.2%, conjunctival injection
79.7%, changes in lips and oral cavity 55.6% and
lymphadenopathy 28.8%. Other clinical findings reported
were: sterile pyuria in 80(20%) patients, nausea and vomit-
ing in 96(24%), abdominal pain in 85(21.3%), gallbladder
distention in 14 (3.5%), transaminase elevation in
120(30%), jaundice in 21(5.1%), irritability in 118(29.5%),
aseptic meningitis in 16(4%), sensorineural hearing loss in
2 patients, uveitis in 11(2.7%) and arthritis or arthralgia in
55(13.8%). Cardiologic findings were: perivascular bright-
ness of the coronary wall in 42(10.5%) patients, pericarditis
in 9(2.3%), myocarditis in 4(1%), mitral regurgitation in 28
(7%) and CA in 53 patients(13.3%), 26(49%) of them disap-
pearing before the 2nd month after the onset of KD. 4
patient had giant CA. Intravenous immunoglobulin (IVIG)
was administered in 389(97.5%) patients with response to
the 1st dose in 332(83.2%). Day of IVIG administration
was 7.5±3.1. Other treatment plans were: 2nd (69%
response) and 3rd IVIG doses, oral or iv corticosteroids
and abciximab (administered in 3 of the patients with
giant CA). 97.7% of patients received anti-platelet dose
aspirin in the convalescent phase.
Conclusion
This is the first population-based study on the epide-
miology of KD in Catalonia (Spain). It seems to be a
higher incidence of CA in our cohort despite high rates
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of treatment response. Further analysis is required.
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